kabutan

Genky DrugStares, First Half Ordinary Profit Increases by 5%

Mon Jan 27, 2025 3:30 pm JST Earnings

9267 Genky DrugStores Co.,Ltd. 【J-GAAP】

Earnings Report

Genky DrugStares Co.,Ltd. <9267> [TSE Prime] announced its financial results after the market closed on January 27th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending June 2025 (July to December) increased 5.1% from the same period last year, reaching 4.72 billion yen. However, the progress rate toward the full-year plan of 10.2 billion yen was 46.2%, almost the same as the five-year average of 45.9%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to June period (2H) is expected to grow 15.2% from the same period last year, reaching 5.49 billion yen.

In the most recent three-month period, from October to December (2Q), the consolidated ordinary profit amounted to 2.42 billion yen, an increase of 0.7% compared to the same period last year. However, the operating profit margin worsened from 5.3% in the same period last year to 4.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jul - Dec, 2022 83,874 3,364 3,561 2,271 74.8 50.3 Jan 31, 2023 J-GAAP
Jul - Dec, 2023 91,967 4,387 4,495 3,087 101.7 48.5 Jan 29, 2024 J-GAAP
Jul - Dec, 2024 98,758 4,596 4,722 3,268 107.6 46.2 Jan 27, 2025 J-GAAP
YoY +7.4% +4.8% +5.1% +5.9% +5.8%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 Guidance 100,000 5,000 5,110 3,500 115.2 6.50 Jul 29, 2024 J-GAAP
Jul - Dec, 2024 Results 98,758 4,596 4,722 3,268 107.6 6.50 Jan 27, 2025 J-GAAP
Revision Rate -1.2% -8.1% -7.6% -6.6% -6.6%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 92,893 4,628 4,773 3,237 106.6 6.50 Jul 29, 2024 J-GAAP
Jan - Jun, 2025 Guidance 103,242 5,404 5,498 3,732 122.8 6.50 Jan 27, 2025 J-GAAP
YoY +11.1% +16.8% +15.2% +15.3% +15.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2023 169,059 6,709 7,079 4,764 156.9 12.50 Jul 24, 2023 J-GAAP
Jun, 2024 184,860 9,015 9,268 6,324 208.2 12.75 Jul 29, 2024 J-GAAP
Jun, 2025 Guidance 202,000 10,000 10,220 7,000 230.3 13 Jul 29, 2024 J-GAAP
YoY +9.3% +10.9% +10.3% +10.7% +10.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 45,096 2,372 2,406 1,643 54.1 5.3 Jan 29, 2024 J-GAAP
Jan - Mar, 2024 44,620 2,107 2,193 1,369 45.1 4.7 Apr 25, 2024 J-GAAP
Apr - Jun, 2024 48,273 2,521 2,580 1,868 61.5 5.2 Jul 29, 2024 J-GAAP
Jul - Sep, 2024 50,050 2,272 2,300 1,584 52.1 4.5 Oct 28, 2024 J-GAAP
Oct - Dec, 2024 48,708 2,324 2,422 1,684 55.4 4.8 Jan 27, 2025 J-GAAP
YoY +8.0% -2.0% +0.7% +2.5% +2.4%

Related Articles